4.6 Letter

Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 168, Issue 1, Pages 145-148

Publisher

WILEY
DOI: 10.1111/bjh.13071

Keywords

non-hodgkin lymphoma; antibody therapy; rituximab; Fc receptor; biomarker

Categories

Funding

  1. Cancer Research UK [A15623] Funding Source: Medline

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available